Home Uncategorised B Strategy Launches $1B BNB Treasury Company With YZi Labs Support as...

B Strategy Launches $1B BNB Treasury Company With YZi Labs Support as Token Nears ATH

105
0

B Strategy has announced the launch of a $1 billion U.S.-listed BNB treasury company, supported by YZi Labs and backed by anchor investors from Asia. The initiative comes as BNB trades close to its all-time high, reflecting strong institutional appetite for structured exposure to the token.

According to the announcement, the firm aims to raise $1 billion to build what it describes as the “Berkshire Hathaway of the BNB ecosystem.” The company’s mission is to hold BNB as a treasury asset under strict governance standards, providing institutional investors with transparency, independent auditing, and robust risk management.

BNB is currently trading at $861, down 1.7% in the past 24 hours but still up nearly 10% over the last month and 38% year-to-date. Over the past 12 months, BNB has surged more than 48% and recently hit a new all-time high, cementing its position as one of the leading crypto assets in terms of institutional adoption.

The firm’s founder, Leon Lu, previously co-founded Metalpha and managed a Bitmain-seeded crypto fund that delivered 276% returns in two years. He emphasized that the new company will maximize BNB per share while adhering to U.S. market standards. Co-founder Max Hua, former Bitmain CFO, confirmed that independent audits and rigorous oversight will be central to operations.

Ella Zhang, head of YZi Labs, described BNB as a core pillar of the next generation of financial markets, noting its role in supporting Web3, stablecoins, and real-world asset adoption.

Meanwhile, Binance founder Changpeng Zhao (CZ) clarified that while YZi Labs is not leading the initiative, it is offering support. He described the effort as “another B Strategy,” highlighting expectations that the project could attract $1 billion in institutional capital.

The move comes amid a wave of corporate interest in structured crypto treasuries. While optimism is high, the industry has seen challenges before—such as Windtree Therapeutics, a U.S.-listed firm that adopted BNB for its treasury but was later delisted from Nasdaq after failing to meet requirements.